 |
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
American Academy of HIV Medicine
AAHIVM'S Fundraising Effort Moves ForwardApril/May 2001 The American Academy of HIV Medicine's fundraising campaign is continuing to enjoy success. This is in part a result of a recent contribution from a new donor, Ortho-Biotech, to support AAHIVM's programs and general operation. The Academy's ongoing fundraising effort, which has already raised well over $1 million in contributions and pledges, enlists support from various sources including pharmaceutical and biotechnology companies, private foundations, and public sector organizations. AAHIVM's Sustaining Charter Members, donors who have made significant contributions to the Academy, include Bristol-Myers Squibb, DuPont, GlaxoSmithKline, Merck, Orth-Biotech, and Roche.
The Academy is also receiving support from Serano and Triangle. This article was provided by American Academy of HIV Medicine. It is a part of the publication The Nexus. |
E-Mail
Printable Single-Page
Glossary
Share
